[
  {
    "workflow_id": "fortune_500_market_entry",
    "workflow_name": "Fortune 500 Market Entry Analysis",
    "industry": "Technology",
    "client_segment": "Fortune 500",
    "execution_date": "2024-01-15T09:00:00Z",
    "completion_date": "2024-01-15T17:45:00Z",
    "total_duration_hours": 8.75,
    "pattern_used": "strategic_analysis_pipeline",
    "business_context": {
      "scenario": "Large enterprise software company evaluating entry into AI-powered customer service automation market",
      "budget": "$50M investment consideration",
      "timeline": "18-month market entry window",
      "key_stakeholders": ["CEO", "CTO", "Head of Strategy", "VP Product"]
    },
    "execution_stages": [
      {
        "stage": "Market Research",
        "agent_id": "researcher_001",
        "start_time": "2024-01-15T09:00:00Z",
        "end_time": "2024-01-15T11:30:00Z",
        "duration_minutes": 150,
        "deliverables": [
          "Market size analysis ($12.4B in 2024, growing 28% CAGR)",
          "Competitive landscape (Zendesk, Salesforce, Microsoft leading)",
          "Customer segment analysis (Mid-market showing fastest adoption)",
          "Technology trends assessment (GenAI integration becoming table stakes)"
        ],
        "sources_used": 34,
        "data_quality_score": 0.91
      },
      {
        "stage": "Financial Analysis",
        "agent_id": "analyst_001", 
        "start_time": "2024-01-15T11:45:00Z",
        "end_time": "2024-01-15T13:15:00Z",
        "duration_minutes": 90,
        "deliverables": [
          "Investment requirements ($35M development, $15M marketing)",
          "Revenue projections (Break-even in 24 months, $120M ARR by year 3)",
          "Cost structure analysis (70% R&D, 20% Sales/Marketing, 10% Operations)",
          "ROI calculations (18% IRR over 5 years)"
        ],
        "financial_models_created": 5,
        "sensitivity_scenarios": 3
      },
      {
        "stage": "Risk Assessment",
        "agent_id": "analyst_002",
        "start_time": "2024-01-15T13:30:00Z", 
        "end_time": "2024-01-15T14:45:00Z",
        "duration_minutes": 75,
        "deliverables": [
          "Technical risks (AI model accuracy, scalability challenges)",
          "Market risks (Competitive response, customer adoption slower than projected)",
          "Regulatory risks (Data privacy, AI governance requirements)",
          "Mitigation strategies for top 10 identified risks"
        ],
        "risks_identified": 23,
        "high_priority_risks": 8
      },
      {
        "stage": "Strategy Synthesis",
        "agent_id": "synthesizer_001",
        "start_time": "2024-01-15T15:00:00Z",
        "end_time": "2024-01-15T17:00:00Z", 
        "duration_minutes": 120,
        "deliverables": [
          "Go-to-market strategy (Partner-first approach, focus on mid-market)",
          "Product roadmap (MVP in 8 months, full platform in 18 months)",
          "Investment recommendation (Proceed with $42M investment)",
          "Success metrics and KPIs (Customer acquisition, retention, NPS)"
        ],
        "recommendation": "PROCEED",
        "confidence_level": 0.85
      },
      {
        "stage": "Quality Review",
        "agent_id": "critic_001",
        "start_time": "2024-01-15T17:15:00Z",
        "end_time": "2024-01-15T17:45:00Z",
        "duration_minutes": 30,
        "deliverables": [
          "Analysis quality assessment (8.5/10 overall)",
          "Methodology validation (Appropriate frameworks used)",
          "Recommendation validation (Conservative projections, sound logic)",
          "Areas for additional research (Competitive response modeling)"
        ],
        "quality_score": 0.89,
        "issues_flagged": 3,
        "recommendations_approved": true
      }
    ],
    "final_outcome": {
      "recommendation": "Proceed with market entry",
      "investment_amount": "$42M over 18 months",
      "expected_roi": "18% IRR, break-even in 24 months",
      "key_success_factors": [
        "Strong product-market fit in mid-market segment",
        "Differentiated AI capabilities",
        "Experienced go-to-market team"
      ],
      "next_steps": [
        "Form cross-functional product team",
        "Initiate technology due diligence",
        "Begin customer discovery interviews"
      ]
    },
    "business_value": {
      "decision_acceleration": "8 hours vs typical 3-4 weeks",
      "cost_savings": "$180K in consultant fees avoided", 
      "confidence_improvement": "High confidence decision vs initial uncertainty"
    }
  },
  {
    "workflow_id": "pharmaceutical_regulatory_analysis",
    "workflow_name": "FDA Drug Approval Pathway Analysis",
    "industry": "Pharmaceuticals",
    "client_segment": "Mid-size Biotech",
    "execution_date": "2024-01-12T08:00:00Z",
    "completion_date": "2024-01-12T16:30:00Z", 
    "total_duration_hours": 8.5,
    "pattern_used": "research_synthesis_parallel",
    "business_context": {
      "scenario": "Biotech company preparing FDA submission for novel diabetes treatment",
      "drug_candidate": "GLP-1 receptor agonist with novel delivery mechanism",
      "current_phase": "Phase II completed, planning Phase III",
      "regulatory_pathway": "Standard approval vs expedited pathways"
    },
    "execution_stages": [
      {
        "stage": "Regulatory Research",
        "parallel_execution": true,
        "agents": [
          {
            "agent_id": "researcher_regulatory_001",
            "specialization": "FDA guidance documents",
            "duration_minutes": 180,
            "deliverables": [
              "Current FDA guidance for diabetes drugs (2023 updates)",
              "Expedited pathway eligibility criteria",
              "Required clinical endpoints and safety data",
              "Recent FDA decisions on similar drug classes"
            ],
            "guidance_documents_reviewed": 18,
            "precedent_cases_analyzed": 12
          },
          {
            "agent_id": "researcher_competitive_001", 
            "specialization": "Competitive intelligence",
            "duration_minutes": 165,
            "deliverables": [
              "Competitive landscape (Ozempic, Mounjaro, Trulicity market position)",
              "Recent approvals and their timelines",
              "Clinical trial designs for approved competitors",
              "Market access and pricing strategies"
            ],
            "competitor_profiles": 8,
            "clinical_trials_analyzed": 15
          },
          {
            "agent_id": "researcher_clinical_001",
            "specialization": "Clinical development",
            "duration_minutes": 200,
            "deliverables": [
              "Phase III trial design recommendations",
              "Primary and secondary endpoint selection",
              "Patient population and inclusion criteria",
              "Statistical powering and sample size calculations"
            ],
            "trial_protocols_reviewed": 22,
            "statistical_models_evaluated": 6
          }
        ]
      },
      {
        "stage": "Synthesis and Recommendations",
        "agent_id": "synthesizer_regulatory_001",
        "start_time": "2024-01-12T14:00:00Z",
        "duration_minutes": 150,
        "deliverables": [
          "Recommended regulatory strategy (Standard pathway with FDA meetings)",
          "Phase III trial protocol outline",
          "Regulatory submission timeline (30 months to BLA submission)",
          "Risk mitigation strategies for key regulatory concerns"
        ],
        "recommendation": "Standard BLA pathway with pre-submission meetings",
        "timeline_estimate": "30 months to approval",
        "probability_of_success": 0.72
      }
    ],
    "final_outcome": {
      "recommended_pathway": "Standard BLA with accelerated review request",
      "estimated_timeline": "30 months development + 12 months FDA review",
      "estimated_costs": "$85M for Phase III + $12M regulatory activities",
      "key_risk_factors": [
        "Cardiovascular safety requirements may extend timeline",
        "Manufacturing scale-up for novel delivery system",
        "Competitive approvals potentially changing standard of care"
      ]
    }
  },
  {
    "workflow_id": "private_equity_due_diligence",
    "workflow_name": "SaaS Company Acquisition Due Diligence", 
    "industry": "Private Equity",
    "client_segment": "Mid-market PE Fund",
    "execution_date": "2024-01-10T09:00:00Z",
    "completion_date": "2024-01-11T18:00:00Z",
    "total_duration_hours": 25,
    "pattern_used": "enterprise_supervisor_coordination",
    "business_context": {
      "scenario": "PE fund evaluating $150M acquisition of HR tech SaaS company",
      "target_company": "Mid-market HRIS provider, $25M ARR",
      "acquisition_multiple": "6x revenue",
      "hold_period": "3-5 years with 3x return target"
    },
    "execution_stages": [
      {
        "stage": "Market Intelligence", 
        "agent_id": "researcher_market_001",
        "duration_hours": 6,
        "deliverables": [
          "HR tech market analysis ($30B market, 12% CAGR)",
          "Competitive positioning vs Workday, BambooHR, Namely",
          "Customer segment analysis and growth opportunities",
          "Technology trends and disruption risks"
        ],
        "market_reports_analyzed": 15,
        "competitor_analysis_depth": "Deep dive on top 12 competitors"
      },
      {
        "stage": "Financial Analysis",
        "agent_id": "analyst_financial_001", 
        "duration_hours": 8,
        "deliverables": [
          "Revenue quality assessment (92% recurring, 8% services)",
          "Unit economics analysis (LTV/CAC = 4.2x, payback 18 months)", 
          "Profitability bridge to 25% EBITDA margins",
          "5-year financial projections with PE value creation plan"
        ],
        "financial_models_built": 3,
        "scenario_analysis": "Base/upside/downside cases",
        "projected_irr": "24% (base case)"
      },
      {
        "stage": "Operational Assessment",
        "agent_id": "analyst_operational_001",
        "duration_hours": 7,
        "deliverables": [
          "Technology stack evaluation (Modern, scalable architecture)",
          "Sales and marketing efficiency analysis",
          "Customer success and retention deep dive (95% gross retention)",
          "Management team assessment and organizational gaps"
        ],
        "operational_kpis_analyzed": 35,
        "improvement_opportunities_identified": 12
      },
      {
        "stage": "Investment Summary",
        "agent_id": "synthesizer_investment_001", 
        "duration_hours": 4,
        "deliverables": [
          "Investment thesis and value creation plan",
          "Key risks and mitigation strategies",
          "100-day post-acquisition plan",
          "Exit strategy and potential acquirer analysis"
        ],
        "recommendation": "PROCEED with acquisition",
        "investment_confidence": 0.83,
        "target_return": "3.2x over 4 years"
      }
    ],
    "final_outcome": {
      "investment_decision": "Proceed with acquisition",
      "offer_price": "$145M (5.8x revenue)",
      "value_creation_levers": [
        "Sales team expansion and process optimization",
        "Product-led growth initiatives", 
        "Strategic add-on acquisitions",
        "International expansion"
      ],
      "projected_returns": "3.2x MOIC, 24% IRR over 4-year hold"
    }
  }
]